nach oben

Erschienen in:

23.07.2021 | COVID-19 | Observational Research Zur Zeit gratis

Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown

verfasst von: Grace Johnstone, Gareth J. Treharne, Benjamin D. Fletcher, Roisin S. M. Lamar, Douglas White, Andrew Harrison, Simon Stebbings

Erschienen in: Rheumatology International | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to investigate the effects of lockdown on the mental health (anxiety and depression) and quality of life (QOL) of people with rheumatoid arthritis (RA) and ankylosing spondylitis (AS) in the context of the COVID-19 pandemic and public health measures instituted at a national level by the New Zealand Government. The present cohort was 104 individuals with RA (73.1%) and AS (26.9%) who had previously completed surveys for the Patient Opinion Real-Time Anonymous Liaison (PORTAL) project in 2018. Participants completed an online survey between July and September 2020 assessing their experiences over the first national COVID-19 lockdown in New Zealand (March–May, 2020). Fear of SARS-CoV-2 infection, baseline anxiety, and being younger in age were all predictors of participants’ current anxiety levels. Current QOL scores were significantly lower than prior to lockdown and were predicted by baseline QOL and current depression. No variables predicted current depression other than baseline levels. The COVID-19 pandemic appears to have had an impact on QOL and anxiety levels, but not depression for people with RA and AS in New Zealand. These novel findings imply that appropriate screening of mental health issues should be included in planning within the ongoing COVID-19 pandemic and for future pandemics to optimise the wellbeing of people with RA and AS.

Baker MG, Kvalsvig A, Verrall AJ, Telfar-Barnard L, Wilson N (2020) New Zealand’s elimination strategy for the COVID-19 pandemic and what is required to make it work. N Z Med J 133(1512):10–14PubMed

Jefferies S, French N, Gilkison C, Graham G, Hope V, Marshall J et al (2020) COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study. Lancet Public Heal 5(11):e612–e623. https://doi.org/10.1016/S2468-2667(20)30225-5CrossRef

Kourbeti IS, Ziakas PD, Mylonakis E (2014) Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: a meta-analysis. Clin Infect Dis 58(12):1649–1657. https://doi.org/10.1093/cid/ciu185CrossRefPubMed

Usher K, Bhullar N, Jackson D (2020) Life in the pandemic: Social isolation and mental health. J Clin Nurs 29(15–16):2756–2757. https://doi.org/10.1111/jocn.15290CrossRefPubMed

Rajkumar RP (2020) COVID-19 and mental health: a review of the existing literature. Asian J Psychiatr 52:102066. https://doi.org/10.1016/j.ajp.2020.102066CrossRefPubMedPubMedCentral

George M, Venkatachalam S, Banerjee S, Baker J, Merkel P, Curtis D et al (2020) Concerns and health-related behaviors during the COVID-19 pandemic in patients with or without autoimmune rheumatic disease in a large physician network [abstract]. Athritis Rheumatol 72(suppl 10):4

Baker MG, Wilson N, Anglemyer A (2020) Successful elimination of Covid-19 transmission in New Zealand. N Engl J Med 383(e56):1–3. https://doi.org/10.1056/NEJMc2025203CrossRef

Robert A (2020) Lessons from New Zealand’s COVID-19 outbreak response. Lancet Public Health 5(11):e569–e570. https://doi.org/10.1016/S2468-2667(20)30237-1CrossRefPubMedPubMedCentral

Zartaloudi A, Koutelekos I, Polikandrioti M, Stefanidou S, Koukoularis D, Kyritsi E (2020) Anxiety and depression in primary care patients suffering of rheumatoid diseases. Psychiatriki 31(2):140–147CrossRefPubMed

10.

Listing J, Strangfeld A, Kary S, Rau R, Von Hinueber U, Stoyanova-Scholz M et al (2020) Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheumatol 52(11):3403–3412. https://doi.org/10.1002/art.21386CrossRef

11.

Zheng YY, Ma YT, Zhang JY, Xie X (2020) COVID-19 and the cardiovascular system. Nat Rev Cardiol 17(5):259–260. https://doi.org/10.1038/s41569-020-0360-5CrossRefPubMed

12.

Sood A, Galestanian A, Murthy V, Gonzalez E, Mukaila R (2020) COVID-19 infection among patients with rheumatic disease on biologic & targeted therapies: a systematic review [abstract]. Arthritis Rheumatol 72(suppl 10):1

13.

Ahmed S, Gasparyan AY, Zimba O (2021) Comorbidites in rheumatic diseases need special consideration during the COVID-19 pandemic. Rheumatol Int 41:243–256. https://doi.org/10.1007/s00296-020-04764-5CrossRefPubMed

14.

D’Silva K, Jorge A, Lu N, Zhang Y, Wallace Z, Choi H (2020) Outcomes of Coronavirus Disease 2019 infection among patients living with rheumatic diseases: a matched cohort study from a US multi-center research network [abstract]. Arthritis Rheumatol 325:25–27

15.

Hill CL, Gill T, Taylor AW, Daly A, Grande ED, Adams RJ (2007) Psychological factors and quality of life in arthritis: a population-based study. Clin Rheumatol 26(7):1049–1054. https://doi.org/10.1007/s10067-006-0439-3CrossRefPubMed

16.

Anyfanti P, Gavriilaki E, Pyrpasopoulou A, Triantafyllou G, Triantafyllou A, Chatzimichailidou S et al (2016) Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated. Clin Rheumatol 35(3):733–739. https://doi.org/10.1007/s10067-014-2677-0CrossRefPubMed

17.

Kool MB, Geenen R (2012) Loneliness in patients with rheumatic diseases: the significance of invalidation and lack of social support. J Psychol 146(1–2):229–241. https://doi.org/10.1080/00223980.2011.606434CrossRefPubMed

18.

Strand V, Singh JA (2007) Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care 13(SUPPL. 9):239–254

19.

Isik A, Koca SS, Ozturk A, Mermi O (2007) Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 26(6):872–878. https://doi.org/10.1007/s10067-006-0407-yCrossRefPubMed

20.

Hong M, Shin H, De Gagne JC (2019) Social networks, health-promoting behaviors, and health-related quality of life in older adults with and without arthritis. PLoS ONE 14(7):1–15. https://doi.org/10.1371/journal.pone.0220180CrossRef

21.

Shah SMA, Mohammad D, Qureshi MFH, Abbas MZ, Aleem S (2020) Prevalence, psychological responses and associated correlates of depression, anxiety and stress in a global population, during the coronavirus disease (COVID-19) pandemic. Community Ment Health J 57:101–110. https://doi.org/10.1007/s10597-020-00728-yCrossRefPubMed

22.

Marques L, Bartuska AD, Cohen JN, Youn SJ (2020) Three steps to flatten the mental health need curve amid the COVID-19 pandemic. Depress Anxiety 37(5):405–406. https://doi.org/10.1002/da.23031CrossRefPubMedPubMedCentral

23.

Glass CA, Cash JC, Mullen J (2020) Coronavirus Disease (COVID-19). World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019

24.

Hämmig O (2019) Health risks associated with social isolation in general and in young, middle and old age. PLoS ONE. https://doi.org/10.1371/journal.pone.0219663CrossRefPubMedPubMedCentral

25.

Evers AWM, Kraaimaat FW, Geenen R, Jacobs JWG, Bijlsma JWJ (2003) Stress-vulnerability factors as long-term predictors of disease activity in early rheumatoid arthritis. J Psychosom Res 55(4):293–302. https://doi.org/10.1016/S0022-3999(02)00632-3CrossRefPubMed

26.

Zautra AJ, Hoffman JM, Matt KS, Yocum D, Potter PT, Castro WL et al (1998) An examination of individual differences in the relationship between interpersonal stress and disease activity among women with rheumatoid arthritis. Arthritis Care Res (Hoboken) 11(4):271–279. https://doi.org/10.1002/art.1790110408CrossRef

27.

Marchetti D, Fontanesi L, Mazza C, Di Giandomenico S, Roma P, Verrocchio MC (2020) Parenting-related exhaustion during the Italian COVID-19 lockdown. J Pediatr Psychol 45(10):1114–1123. https://doi.org/10.1093/jpepsy/jsaa093CrossRefPubMed

28.

Geenen R, Van Middendorp H, Bijlsma JWJ (2006) The impact of stressors on health status and hypothalamic-pituitary-adrenal axis and autonomic nervous system responsiveness in rheumatoid arthritis. Ann N Y Acad Sci 1069:77–97. https://doi.org/10.1196/annals.1351.007CrossRefPubMed

29.

Thomason BT, Brantley PJ, Jones GN, Dyer HR, Morris JL (1992) The relation between stress and disease activity in rheumatoid arthritis. J Behav Med 15(2):215–220. https://doi.org/10.1007/BF00848326CrossRefPubMed

30.

Brady SM, Fenton SAM, Metsios GS, Bosworth A, Duda JL, Kitas GD et al (2021) Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-19. Rheumatol Int 41:335–344. https://doi.org/10.1007/s00296-020-04751-wCrossRefPubMed

31.

Taylor S, Landry CA, Paluszek MM, Fergus TA, McKay D, Asmundson GJG (2020) COVID stress syndrome: concept, structure, and correlates. Depress Anxiety 37(8):706–714. https://doi.org/10.1002/da.23071CrossRefPubMed

32.

Coyle CE, Dugan E (2012) Social isolation, loneliness and health among older adults. J Aging Health 24(8):1346–1363. https://doi.org/10.1136/bmj.m1166CrossRefPubMed

33.

Mahase E (2020) Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence. BMJ 368(March):m1166. https://doi.org/10.1136/bmj.m1166CrossRefPubMed

34.

Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G et al (2020) Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 382(25):2411–2418. https://doi.org/10.1056/NEJMoa2012410CrossRefPubMed

35.

Mendel A, Bernatsky S, Thorne JC, Lacaille D, Johnson SR, Vinet É (2020) Hydroxychloroquine shortages during the COVID-19 pandemic. Ann Rheum Dis 80(3):31CrossRef

36.

Evers AWM, Zautra A, Thieme K (2011) Stress and resilience in rheumatic diseases: a review and glimpse into the future. Nat Rev Rheumatol 7(7):409–415. https://doi.org/10.1038/nrrheum.2011.80CrossRefPubMed

37.

Devadula S, Langbecker D, Vecchio P, Tesiram J, Meiklejohn J, Benham H (2020) Tele-rheumatology to regional hospital outpatient clinics: patient perspectives on a new model of care. Telemed J E Health 26(7):912–919. https://doi.org/10.1089/tmj.2019.01119CrossRefPubMed

38.

Knitza J, Simon D, Lambrecht A, Raab C, Tascilar K, Hagen M et al (2020) Mobile health usage, preferences, barriers, and eHealth literacy in rheumatology: patient survey study. JMIR Mhealth Uhealth 8(8):e19661. https://doi.org/10.2196/19661CrossRefPubMedPubMedCentral

39.

Khilnani A, Schulz J, Robinson L (2020) The COVID-19 pandemic: new concerns and connections between eHealth and digital inequalities. J Information, Commun Ethics Soc 18(3):393–403. https://doi.org/10.1108/JICES-04-2020-0052CrossRef

40.

Thombs BD, Tao L, Wu Y, Levis B, Sun Y, Bourgeault A, et al (2020) Preliminary COVID-19 fears questionnaire: systemic sclerosis and chronic medical conditions versions. OSF Preprints https://doi.org/10.31219/osf.io/m2ybt

41.

Burckhardt CS, Anderson KL (2003) The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes 77(Suppl):1–75. https://doi.org/10.1186/1477-7525-1-60CrossRef

42.

Zigmond AS, Snaith RP (1982) The hospital anxiety and depression scale. Occup Med (Chic Ill) 64(5):393–394. https://doi.org/10.1111/j.1600-0447.1983.tb09716.xCrossRef

43.

Hegarty RSM, Conner TS, Stebbings S, Treharne GJ (2015) Feel the fatigue and be active anyway: physical activity on high-fatigue days protects adults with arthritis from decrements in same-day positive mood. Arthritis Care Res 67(9):1230–1236. https://doi.org/10.1002/acr.22582CrossRef

44.

Kirwan JR, Reeback JS (1986) Stanford health assessment questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 25(2):206–209. https://doi.org/10.1093/rheumatology/25.2.206CrossRefPubMed

45.

Gross C, Hen R (2004) The developmental origins of anxiety. Nat Rev Neurosci 5(7):545–552. https://doi.org/10.1038/nrm1429CrossRefPubMed

46.

Rosenberg H, Syed S, Rezaie S (2020) The Twitter pandemic: the critical role of Twitter in the dissemination of medical information and misinformation during the COVID-19 pandemic. CJEM 22(4):418–421. https://doi.org/10.1017/cem.2020.361CrossRefPubMed

47.

Bish A, Michie S (2010) Demographic and attitudinal determinants of protective behaviours during a pandemic: a review. Br J Health Psychol 15(4):797–824. https://doi.org/10.1348/135910710X485826CrossRefPubMedPubMedCentral

48.

Pierce M, Hope H, Ford T, Hatch S, Hotopf M, John A et al (2020) Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population. Lancet Psychiatry 7(10):883–892. https://doi.org/10.1016/S2215-0366(20)30308-4CrossRefPubMedPubMedCentral

49.

Posadzki P, Mastellos N, Ryan R, Gunn LH, Felix LM, Pappas Y et al (2016) Automated telephone communication systems for preventive healthcare and management of long-term conditions. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD009921.pub2CrossRefPubMedPubMedCentral

50.

Hartnett M (2017) Differences in the digital home lives of young people in New Zealand. Br J Educ Technol 48(2):642–652CrossRef

Titel: Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown
verfasst von: Grace Johnstone
Gareth J. Treharne
Benjamin D. Fletcher
Roisin S. M. Lamar
Douglas White
Andrew Harrison
Simon Stebbings
Publikationsdatum: 23.07.2021
Verlag: Springer Berlin Heidelberg
Schlagwort: COVID-19
Erschienen in: Rheumatology International / Ausgabe 10/2021
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-021-04952-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2021

Assessment of the responsiveness of four scales in geriatric patients with chronic neck pain

Effects of the SARS-CoV-2 global pandemic on U.S. rheumatology outpatient care delivery and use of telemedicine: an analysis of data from the RISE registry

Syndrome of progressive deforming non-inflammatory arthritis of childhood: two patients of camptodactyly-arthropathy-coxa vara-pericarditis syndrome

Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype

Decrease in handgrip strength in rheumatoid arthritis (RA): is there a sex-related difference?

Temporal artery biopsy for suspected giant cell arteritis: a retrospective analysis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin